The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

被引：0
|
作者：
Piotr Rutkowski
Elżbieta Bylina
Anna Klimczak
Tomasz Świtaj
Sławomir Falkowski
Jacek Kroc
Iwona Ługowska
Magdalena Brzeskwiniewicz
Wojciech Melerowicz
Czesław Osuch
Ewa Mierzejewska
Kacper Wasielewski
Agnieszka Woźniak
Urszula Grzesiakowska
Zbigniew I Nowecki
Janusz A Siedlecki
Janusz Limon
机构：
[1] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,Department of Soft Tissue/Bone Sarcoma and Melanoma
[2] Pfizer Poland,Department of Biology and Genetics
[3] Medical University of Gdansk,Department of General Surgery
[4] GreaterPoland Oncological Center,Department of Biostatistics
[5] Jagiellonian University,Laboratory of Experimental Oncology and Department of General Medical Oncology
[6] Medical Faculty,Department of Radiology
[7] Institute of Mother and Child,Department of Gastrointestinal Tumors
[8] KU Leuven and University Hospital,Department of Molecular Biology
[9] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[10] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[11] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
来源：
BMC Cancer | / 12卷
关键词：
Sunitinib; Genotype; GIST; Prognosis; Predictive factors; Arterial hypertension;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [31] Definition of an imatinib trough concentration threshold in the treatment of advanced gastrointestinal stromal tumors (GIST).
    Molimard, M.
    Bouchet, S.
    Poulette, S.
    Chauzit, E.
    Titier, K.
    Moore, N.
    Lassalle, R.
    Abouelfath, A.
    Italiano, A.
    Chevreau, C.
    Duffaud, F.
    Rios, M.
    Cupissol, D.
    Adenis, A.
    Ray-Coquard, I. L.
    Bouche, O.
    Le Cesne, A.
    Blay, J.
    Nguyen, B. Bui
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Systemic Therapy for Advanced Gastrointestinal Stromal Tumors: Beyond Imatinib
    Kim, Edward J.
    Zalupski, Mark M.
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (08) : 901 - 906
  • [33] Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure
    Sobczuk, Pawel
    Teterycz, Pawel
    Lugowska, Iwona
    Klimczak, Anna
    Bylina, Elzbieta
    Czarnecka, Anna M.
    Kosela-Paterczyk, Hanna
    Osuch, Czeslaw
    Streb, Joanna
    Rutkowski, Piotr
    ONCOLOGY LETTERS, 2019, 18 (03) : 3373 - 3380
  • [34] Gastrointestinal stromal tumors (GIST):: factors predictive of survival after R0-cytoreduction
    Sanchez Hidalgo, J. M.
    Munoz Casares, F. C.
    Rufian Pena, S.
    Naranjo Torres, A.
    Ciria Bru, R.
    Briceno Delgado, J.
    Lopez Cillero, P.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2007, 99 (12) : 703 - 708
  • [35] Efficacy and safety of palbociclib in patients with advanced gastrointestinal stromal tumors refractory to imatinib and sunitinib
    Italiano, A.
    Adenis, A.
    Blay, J-Y.
    Duffaud, F.
    Rios, M.
    Bompas, E.
    Bouche, O.
    Pulido, M.
    Le Cesne, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study
    Kang, Hye Jin
    Ryu, Min-Hee
    Kim, Kyoung-Mee
    Park, Young Soo
    Choi, Jene
    Ryoo, Baek-Yeol
    Kim, Woo Ho
    Im, Seock-Ah
    Bang, Yung-Jue
    Park, Se Hoon
    Lee, Jae-Hyuk
    Chung, Ik Joo
    Bae, Han-Ik
    Kim, Jong Gwang
    Lee, Kyung Hee
    Song, Hong Suk
    Kwon, Hyuk-Chan
    Baek, Jin Ho
    Shin, Dong Bok
    Lee, Kyoung Eun
    Kang, Yoon-Koo
    ACTA ONCOLOGICA, 2012, 51 (04) : 528 - 536
  • [37] Sunitinib versus imatinib dose escalation after failure of imatinib standard dose in patients with advanced Gastrointestinal stromal tumors - a real-world multi-center study
    Huang, Shaoqing
    Liu, Xing
    Guo, Xiaodan
    Wu, Hui
    Lu, Huishan
    Pan, Zhizhong
    Cai, Shirong
    Wu, Xiaojun
    Zhang, Xinhua
    TRANSLATIONAL ONCOLOGY, 2023, 30
  • [38] Early assessment of MCV to predict clinical outcome in patients with advanced gastrointestinal stromal tumors (GIST) receiving imatinib.
    Constantinidou, Anastasia
    Krikelis, Dimitrios
    Olmos, David
    Scurr, Michelle R.
    Jones, Robin Lewis
    Ashley, Sue
    Judson, Ian Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Sunitinib—a new approach following failure of imatinib in patients with advanced gastrointestinal stromal tumor
    Maria Debiec-Rychter
    Nature Clinical Practice Oncology, 2007, 4 : 342 - 343
  • [40] Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib
    Kim, Jae-Joon
    Ryu, Min-Hee
    Yoo, Changhoon
    Beck, Mo Youl
    Ma, Jung Eun
    Kang, Yoon-Koo
    ONCOLOGIST, 2019, 24 (11): : E1212 - E1218
12345